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Summary
Objective: Injury or removal of the knee meniscus leads to progressive joint degeneration, and current surgical therapies for meniscal tears
seek to maximally preserve meniscal structure and function. However, the factors that inﬂuence intrinsic repair of the meniscus are not well
understood. The goal of this study was to investigate the capacity of meniscus tissue to repair a simulated defect in vitro and to examine the
effect of pro-inﬂammatory cytokines on this process.
Methods: Cylindrical explants were harvested from the outer one-third of medial porcine menisci. To simulate a full-thickness defect, a central
core was removed and reinserted immediately into the defect. Explants were cultured for 2, 4, or 6 weeks in serum-containing media in the
presence or absence of interleukin-1 (IL-1) or tumor necrosis factor alpha (TNF-a), and meniscal repair was investigated using mechanical
testing and ﬂuorescence confocal microscopy.
Results: Meniscal lesions in untreated samples showed a signiﬁcant capacity for intrinsic repair in vitro, with increasing cell accumulation and
repair strength over time in culture. In the presence of IL-1 or TNF-a, no repair was observed despite the presence of abundant viable cells.
Conclusions: This study demonstrates that the meniscus exhibits an intrinsic repair response in vitro. However, the presence of pro-inﬂam-
matory cytokines completely inhibited repair. These ﬁndings suggest that increased levels of pro-inﬂammatory cytokines post-injury or under
arthritic conditions may inhibit meniscal repair. Therefore, inhibition of these cytokines may provide a means of accelerating repair of damaged
or injured menisci in vivo.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The menisci are intra-articular ﬁbrocartilaginous structures
that play essential roles in the biomechanical function of the
knee joint, including load transmission, shock absorption,
stability, and lubrication1e4. Meniscal tissue is composed of
approximately 70% water, 20% collagen (predominantly
type I and smaller amounts of types II, III, V, VI), with smaller
quantities of proteoglycans and non-collagenous proteins,
lipids, and cells5. The meniscus is a highly inhomogeneous
tissue, exhibiting regional differences in composition, struc-
ture, and cell phenotype6,7. Theextracellularmatrix is synthe-
sized and maintained by several subpopulations of cells that
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Received 7 August 2006; revision accepted 3 March 2007.105have a range of ﬁbroblastic or chondrocytic phenotypes. For
example, cells of the inner radial two-thirds of the meniscus
exhibit a rounded morphology and high messenger RNA
(mRNA) levels for chondrocytic markers such as type II colla-
gen and aggrecan, while the outer one-third of the meniscus
is populated with elongated cells that exhibit characteristics
of a more ﬁbroblast-like phenotype, such as extensive
cellular processes and expression of collagen type I
mRNA8e10. Similar to other cartilaginous tissues, the meta-
bolic activity of meniscal cells is strongly inﬂuenced by
factors in the microenvironment, including soluble mediators
such as growth factors or cytokines11e15, or physical factors
such as mechanical compression or stretch9,16e22.
There is strong evidence that even partial removal of the
menisci leads to joint instability23 and eventually joint de-
generation24e28. Thus, in current surgical practice, efforts
are made to repair meniscal tears instead of removing dam-
aged meniscal tissue whenever. Good clinical outcomes
are generally obtained with reconstruction of tears, espe-
cially in the outer, vascularized region of the meniscus29e31.
However, a number of factors may contribute to the suc-
cess of a meniscal repair procedure, including the degener-
ative state of the joint, the site of the injury, and the
presence of additional joint injuries, such as rupture of the
anterior cruciate ligament (ACL). Meniscal tears that occur
in ACL-intact knees are more degenerative in nature and3
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more often occur in ACL-deﬁcient knees32e34. It is notable
that surgical repair of meniscus is generally very effective
in patients who do not have severe cartilage damage or
degenerative joint changes29,35,36. However, patients with
more severe cartilage lesions exhibit a signiﬁcantly higher
number of degenerative meniscus tears, which generally
exhibit poor outcomes with surgical repair37.
Joint injury, as well as degenerative joint diseases such
as osteoarthritis or rheumatoid arthritis, is characterized
by increased activity of the pro-inﬂammatory cytokines
interleukin-1 (IL-1) and tumor necrosis factor alpha
(TNF-a)38e40. Furthermore, direct injury of the meniscus
during surgery can induce prolonged upregulation of
IL-141. The inﬂammatory activities of these cytokines in
the joint are partially due to increased production of pro-
inﬂammatory mediators such as nitric oxide (NO) and
prostaglandin E2 (PGE2)
42. Furthermore, meniscal cells
themselves exhibit pro-inﬂammatory capabilities and can
synthesize signiﬁcant levels of NO or PGE2 when exposed
to cytokines12,14,22 or biomechanical stress9,16,17,19,21,22.
This upregulation of pro-inﬂammatory mediators in injured
or arthritic joints, when combined with cytokines produced
endogenously by meniscal cells, may act to suppress ma-
trix biosynthesis and increase enzymatic degradation. How-
ever, the inﬂuence of these factors on the repair capacity of
the meniscus is not known.
A number of in vitro studies have examined the repair
properties of articular cartilage43e46 or meniscus47e52. In
one study, for example, an organ culture model was used
to examine the repair of full-thickness defects in human me-
nisci that were ﬁlled with autologous synovium, where it
was shown that cells could migrate along the synovium
and bridge the defect47. Fibrochondrocytes derived from
New Zealand white rabbit menisci were shown to invade
defects ﬁlled with ﬁbrinogen and human thrombin48. In ca-
nine medial menisci, devitalized meniscal cores were re-
placed in vivo and repopulated with cells that expressed
alpha smooth muscle actin, suggesting that the presence
of these cells may be essential for repopulation and integra-
tion of meniscal tissues50. In other studies, it has been
shown that superﬁcial zone cells in the meniscus can
migrate into such a defect and repopulate an acellular
meniscus plug, assisting in wound healing of the meniscus
in vitro51. In other studies, intrinsic repair of meniscal tears
in a whole meniscus organ culture model was demon-
strated by histologic analysis49. These studies have pro-
vided valuable insights on the potential for meniscus
repair in explant culture models, but there have been no di-
rect quantitative measures of repair strength or investiga-
tions of the impact of different cytokines on healing of
meniscus lesions.
The goal of this study was to investigate the repair
capacity of meniscus tissue in vitro and to examine the
effect of pro-inﬂammatory cytokines on meniscus healing.
In a recent study, we reported a novel model to study
the meniscal repair, which showed similar intrinsic repair
responses between the inner and outer porcine meniscus
in vitro52. In this study, cylindrical explants were harvested
from the femoral surface of the outer one-third of medial
porcine menisci. To simulate a full-thickness defect, a
central core was removed and reinserted immediately.
Explants were cultured for 2, 4, and 6 weeks in the pres-
ence or absence of IL-1 or TNF-a, and meniscal repair
was investigated using mechanical testing and ﬂuores-
cence confocal microscopy to measure cellular accumula-
tion in the defect site.Materials and methods
MENISCUS SPECIMENS
Medial menisci were harvested from knee joints of 2- to 3-
year-old skeletally mature female pigs obtained from a local
slaughterhouse within 4 h of death. Under aseptic condi-
tions, cylindrical explants (8 mm in diameter) were har-
vested from the peripheral, outer one-third of the femoral
surface of the menisci using a biopsy punch (Miltex Instru-
ment Company, Inc., Lake Success, NY), which was
inserted perpendicular to the femoral surface. A central
4 mm core was punched from the middle of each 8 mm
explant, again perpendicular to the femoral surface, taking
care to completely separate the two parts. The inner core
was replaced into the outer ring immediately (Fig. 1). To
obtain specimens of uniform height, explants were cut along
the bottom surface to a thickness of 2 mm parallel to the
femoral surface, taking care to maintain the collagen ﬁber
alignment of the two concentric explants. Adjacent samples
from each meniscus were paired at harvest, and one spec-
imen was assigned to the treatment group (IL-1 or TNF-a),
while the other specimen was used as its paired control.
Only menisci without tears or visible degenerative changes
were used for the study.
After harvest, specimens were incubated in 4 ml of base
culture medium (Dulbecco’s Modiﬁed Eagle Medium)
(Gibco, Grand Island, NY) with 10% heat-inactivated fetal
bovine serum (HyClone, Logan, UT), 0.1 mM non-essential
amino acids (Gibco), 10 mM 4-(2-hydroxyethyl) piperazine-
1-ethanesulfonic acid (HEPES) buffer solution (Gibco))
with 1000 U/ml penicillin/streptomycin (Gibco) at 37C, 5%
CO2, and 95% air. After 1 h, culture medium was changed
to medium with 100 U/ml penicillin/streptomycin, and sam-
ples were cultured for 72 h to allow equilibration of cell
metabolic activity in culture21,22. Samples were subse-
quently cultured in the presence or absence of 10 ng/ml
recombinant porcine IL-1a or 10 ng/ml recombinant porcine
TNF-a (R&D Systems), and media was changed to 4 ml of
base culture medium (described above) with 100 U/ml pen-
icillin/streptomycin, and 37.5 mg/ml ascorbate-2-phosphate
(Sigma-Aldrich, St Louis, MO) every 3 days. Samples
were incubated at 37C, 5% CO2, and 95% air for 2, 4,
and 6 weeks with media changes every 3 days. Samples
originated from 42 different animals, and a total of n¼ 108
explants were used for mechanical testing and n¼ 12 sam-
ples for ﬂuorescence cell viability analysis.
GROSS APPEARANCE
The macroscopic appearance of meniscus explants was
recorded when samples were investigated at 2, 4, and 6
weeks. Samples were inspected as to whether openings
had occurred between the outer ring and the inner core.
The inner core was examined for changes in position or
movement relative to the outer ring.
MECHANICAL TESTING OF REPAIR STRENGTH
Interfacial shear strength of the repair between the sur-
faces of the inner core and the outer ring of the explants
was determined using a push-out test on an electromechan-
ical materials testing system (ELF 3200 Series, EnduraTEC
Systems Corp., Minnetonka, MN). The specimens, consist-
ing of an 8 mm diameter outer ring and 4 mm inner core,
were placed in a custom-built testing ﬁxture that consisted
of a suspended cup with a central 5 mm thru-hole in its
base, as described previously52. Explants were aligned
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Fig. 1. Medial meniscus showing (a) location of explants harvested from the outer one-third of the femoral surface of the menisci. (b) Side view
of the explant in situ. (c) A central 4 mm core was punched from the middle of each 8 mm explant and immediately replaced. Square shows the
site and orientation of specimens taken for confocal microscopy. Adjacent explants were site-matched and paired at harvest.with the inner core centered over the thru-hole, allowing it to
be freely pushed from the outer annulus by a 3 mm diameter
rod. A tare load of 0.2 grams-force was applied to the central
core to ensure contact between the sample and the pushing
rod. After equilibration of the tare load, the rod was displaced
at a rate of 0.0833 mm/s until the inner core was completely
separated from the outer ring. Force measurements were
recorded throughout the duration of the test using a load
cell (Sensotec Model 31/6775-06) mounted in-line between
the pushing rod and the electromechanical actuator.
Specimen thickness was measured using a custom-built
vision system consisting of a digital video camera (Model
XDC-X700, Sony Electronics, Park Ridge, NJ) with a 44 mm
video lens (Inﬁnity, Boulder, CO). Images were acquired
and analyzed using LabVIEW Vision Builder AI for Win-
dows (National Instruments Corp., Austin, TX). Shear
stress (t) was then calculated from the core thickness
and force according to t¼ F/(p d h) where, F is the
peak force required to push the inner core completely
through the outer annulus, d is the core diameter, and
h is the core thickness. Repair strength was reported as
the peak shear stress during the push-out test.CELL VIABILITY AND STRUCTURE OF HEALING TISSUE
Cell viability and accumulation were investigated at vari-
ous time-points (2, 4, and 6 weeks) using a ﬂuorescent
live/dead assay (Molecular Probes, Eugene, OR). Explants
were washed in Dulbecco’s phosphate buffered saline
(PBS) (Gibco, Gaithersburg, MD) and incubated for
20 min in PBS containing 1 mg/ml calcein AM as a label of
viable cells and 6 mg/ml ethidium homodimer-1 as a label
of dead cells (Liveedead Assay, Invitrogen, Eugene OR).
Explants were rinsed in PBS to remove unincorporated
stain and placed with the femoral surface of the meniscus
down in a Lab-Tek chambered coverglass containing PBS
(see Fig. 1 for orientation). Images were obtained using
a confocal laser scanning microscope (LSM 510, Zeiss,
Thornwood, NY).
STATISTICAL ANALYSIS
A two-factor analysis of variance with repeated measures
and a NewmaneKeuls post hoc test was used to determine
differences in the repair strength of control samples and
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using the push-out test. Signiﬁcance is reported at the
95% conﬁdence level.
Results
GROSS APPEARANCE
At the 2, 4, and 6 weeks harvest times, both control and
treated samples showed no apparent differences in macro-
scopic appearance. There were no visible openings along
the interface between the outer ring and the inner core,
and no samples had overt signs of infection at any time-
point.
MECHANICAL TESTING OF REPAIR STRENGTH
Mechanical testing revealed a signiﬁcant increase in the
strength of repair over time in control specimens. Control
samples showed a statistically signiﬁcant increase in
strength from 2 weeks to 6 weeks (P< 0.001) and 4 weeks
to 6 weeks (P< 0.001).
The presence of IL-1 signiﬁcantly reduced the shear
strength at all time-points compared to controls (P< 0.001),
and no signiﬁcant changes in repair strength were observed
in the treatedgroupsover the6weekcultureperiod [Fig. 2(a)].
TNF-a signiﬁcantly reduced the shear strength of repair
at all time-points as compared to control specimens
(P< 0.001). In the TNF-a treated group, no signiﬁcant
changes in repair strength were observed with time of the
6 week culture period [Fig. 2(b)]. Samples treated with
TNF-a showed a trend of higher shear strengths as com-
pared to samples exposed to IL-1, although this comparison
was not analyzed statistically.
CELL VIABILITY AND STRUCTURE OF HEALING TISSUE
In control groups, the ﬂuorescence viability assay re-
vealed viable cells within the defect and the presence of
cell clusters in numerous sites by 2 weeks. Cells appeared
connected via cellular processes and bridged the artiﬁcially
created defect [Fig. 3(a)]. In samples treated with IL-1, no
cellular proliferation was evident, and only a few cells cov-
ered the adjacent surfaces of both the inner core and the
outer ring of each specimen [Fig. 3(b)]. In samples exposed
to TNF-a, only one layer of cells covered the surfaces of the
defect at a few points, and no bridging of the gap was
observed [Fig. 3(c)]. In comparison to IL-1 treatment
groups, explants treated with TNF-a showed more cellular
accumulation and invasion into the tissue gap by 2 weeks.
At 4 weeks of culture, further cellular accumulation in the
defect interface was evident in the control group, with an
increased number of cells present in the repair site and fur-
ther connections between these cells [Fig. 3(d)]. In the IL-1
group, more viable cells were present as compared to the
2 week time-point, but no cells were observed in the gap
[Fig. 3(e)]. In samples treated with TNF-a, cells covered
the surface of the defect with several cell layers, but there
was no network extending across the gap [Fig. 3(f)]. At
6 weeks of culture, the gap in control explants was entirely
ﬁlled with meniscal cells, which completely bridged the tis-
sue interface [Fig. 3(g)]. In samples treated with IL-1, the
defect surfaces were covered with several cell layers, but
there was no accumulation of cells into the gap
[Fig. 3(h)]. In samples cultured with TNF-a, cells covered
the surfaces of both the inner core and outer ring of eachspecimen, but bridged the gap in only a few locations
[Fig. 3(i)].
Discussion
Our studies show that meniscal tissue has the ability in
vitro to partially repopulate a defect with cells and tissue, ex-
hibiting the initial characteristics of tissue repair. Under
control conditions, cells accumulated in the defect gap
over several days, increasingly spanning the gap over the
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Fig. 2. Interfacial shear strength of repair over time in culture.
(a) Interfacial shear strength of control (untreated) explants and
explants treated with 10 ng/ml IL-1 at 2, 4, and 6 weeks of culture.
(b) Interfacial shear strength of control (untreated) explants and
explants treated with 10 ng/ml TNF-a at 2, 4, and 6 weeks of
culture. Data are presented as mean S.E.M. (n¼ 9 per treatment
and time-point, *P< 0.05, ***P< 0.001).
1057Osteoarthritis and Cartilage Vol. 15, No. 9Fig. 3. Cell viability and migration investigated by a ﬂuorescent live/dead assay using a confocal laser scanning microscope at the tissue
interface. At 2 weeks, (a) in the control group, partial bridging of the defect was observed; (b) in samples treated with IL-1, no cellular accu-
mulation was evident; (c) in samples treated with TNF-a, one layer of cells had covered the defect on some locations, but no bridging of the
gap was visible. At 4 weeks of culture, (d) in the control group, further cellular migration and accumulation into the gap was observed. In con-
trast, no cellular migration was seen in samples treated with IL-1 (e) and TNF-a (f). After 6 weeks of culture, (g) in the control group, the gap
was completely ﬁlled by cells; (h) in samples treated with IL-1, the defect was covered with up to two cell layers, but no cells were observed
bridging the tissue gap; (i) in samples treated with TNF-a, cells had bridged the gap in a few areas. Scale bar¼ 100 mm.culture period. However, in the presence of either IL-1 or
TNF-a, cell accumulation and intrinsic repair were abol-
ished. These inhibitory effects were not the result of menis-
cal cell death since both control and cytokine-treated
explants showed high cell viability throughout the culture
period. These ﬁndings suggest that the intrinsic ability for
meniscal tissue to repair a lesion may be inhibited or
delayed in vivo due to local increases in pro-inﬂammatory
cytokines such as IL-1 or TNF-a.
Joint injury, as well as acute or chronic arthritis, is charac-
terized by increased concentrations of IL-1 and TNF-a in
the joint as well as the meniscus41,53,54. These mediators
can suppress matrix biosynthesis and increase enzymatic
degradation of various joint tissues39,55, including the
meniscus14,19,22,38. Although the mechanisms involved in
meniscal repair are not fully understood, our in vitro ﬁndingssuggest that meniscus repair in vivo may be inhibited by
joint inﬂammation associated with injury or arthritis. In con-
trol samples, the repair process was characterized by the
accumulation of cells within the tissue gap, presumably
through a combination of cell migration and proliferation,
followed by formation of tissue within the defect site. In
specimens treated with IL-1 or TNF-a, neither cellular accu-
mulation nor tissue formation was observed, suggesting
that these cytokines inhibited integrative repair by inﬂuenc-
ing cell migration and/or proliferation in the tissue gap, or by
altering the balance of biosynthetic and degradative activity
of the meniscal cells.
In previous studies, in vitro models of integrative repair of
cartilaginous tissues have proven useful for the study of
speciﬁc factors related to the repair processes43e46,56,57.
For example, previous studies have shown that collagen
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determining the strength of articular cartilage integration
in vitro44e56. While these factors speciﬁcally have not been
investigated in the meniscus, our ﬁndings are consistent
with previous studies that have demonstrated that cell
migration is required for in vitro meniscal repair47e52. In re-
lated work, we have shown similar repair capacity in vitro of
the inner, avascular region of the meniscus as compared to
the outer vascularized region52, suggesting that the pres-
ence of a vascular supply may contribute to the improved
repair capabilities of the outer zone observed in vivo. The
present study extends the work of others by documenting
that IL-1 and TNF-a potently inhibit meniscus repair. We
also showed with ﬂuorescence microscopy that cell viability
was not decreased in cytokine-treated samples, suggesting
that inhibition of repair results from changes in cell function
rather than cell death. Recent studies have shown in-
creases in metalloproteinases in the meniscus in response
to IL-158. Increased enzymatic activity of the meniscal cells,
coupled with suppression of biosynthesis of structural com-
ponents such as collagen might contribute to the cytokine-
mediated decreases in the repair processes.
In summary, we describe a novel model for the assess-
ment of the effects of various factors on meniscal repair
in vitro. The primary advantages of this approach are the
ability to examine speciﬁc mechanisms involved in promot-
ing or suppressing repair processes, and to perform quanti-
tative measures of repair strength. Using this model, we
observed that IL-1 and TNF-a potently inhibit meniscal re-
pair, suggesting that treatment with anti-cytokine agents
(e.g., antibodies, soluble receptors, or receptor antagonists)
might provide a means of accelerating repair of damaged or
injured menisci in vivo. The ﬁndings of this study should be
interpreted in light of other factors within the synovial envi-
ronment that may affect meniscal physiology and repair,
such as biomechanical stress9,17,19,21,22,59, growth fac-
tors13,15, or other joint pathologies24,37.
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